ISBN: Table 99: Study details (arranged by strata) First Author / Trial name n. Country Recruitment HFRE F or both Start s inpat ient QoL Outcomes: Mort/ Hosp Meds Length (months ) Last measure (months ) Face-to- face meeting s High Risk - Short interventions 98 Ireland Inpatients admitted with primary diagnosis HF both Yes Deaths, Admissions outpt 112 UK Patients that had been referred by GP for open access echo due to suspected HF, who had confirmed LVSD both No Death, Admissions High Risk - Mid-length interventions PREFER trial 72 Sweden Outpatients at geriatrics dept or PC with NYHA III-IV plus one of five markers of need for palliation both No EQ-5D (appears to be VAS) Deaths, Admissions 28 Australia Patients with HFREF from clinic for complex heart failure patients on sub- maximal medication doses HFRE F No MLWHF Death, Admissions 230 Canada Seen in ED or admitted with primary diagnosis HF Most HFRE F On dc Deaths, admissions Sweden Inpatients aged >65y screened for HF, NYHA III-IV both On dc Change in NYHA Death, Admission Gonzalez-Guerrero 117 Spain Admitted under geriatric department with acute HF both Yes Death or admission J-HOMECARE trial Tsuchihashi-makaya 168 Japan From cardiology hospital both Yes SF-8 Deaths, Admissions Referral and approach to care Chronic Heart Failure NICE 2018. All rights reserved. Subject to Notice of rights. ISBN: First Author / Trial name n. Country Recruitment HFRE F or both Start s inpat ient QoL Outcomes: Mort/ Hosp Meds Length (months ) Last measure (months ) Face-to- face meeting s 200 Italy Inpatients <86y screened for congestive HF both Yes MLWHF Deaths, Admissions outpt High Risk - Long interventions Auckland-HF Zealand Admitted with HF both On dc MLWHF Q Deaths. 